|
Dr. Curd is President and Chief Medical Officer of Novacea. From June 1999 to May 2001, Dr. Curd served as Executive Vice President at VaxGen, Inc., a vaccine company. From December 1991 to June 1999, Dr. Curd served in various positions, including Vice President of Clinical Development at Genentech. While at Genentech, he directed the clinical development of Herceptin�, Rituxan�, Xolair and Raptiva. From 1978 to 1991, Dr. Curd served in various positions, including President of the Medical Staff at Scripps Clinical and Research Foundation, La Jolla, California.
Dr. Curd holds a B.S. in chemistry from Princeton University and an M.D. from Harvard Medical School. | 